Use of bisphosphonates in cancer patients
- 1 July 1996
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 22 (4), 265-287
- https://doi.org/10.1016/s0305-7372(96)90020-1
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia modelsBone, 1995
- Effects of two novel bisphosphonates on bone cells in vitroBone and Mineral, 1994
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993
- Urinary pyridinium cross-links as markers of bone resorption in tumor- associated hypercalcemiaJournal of Clinical Endocrinology & Metabolism, 1992
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Journal of Clinical Investigation, 1991
- PamidronateDrugs, 1991
- A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and ExpressionScience, 1987
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- Quantitative Bone Histomorphometry in Humoral Hypercalcemia of Malignancy: Uncoupling of Bone Cell Activity*Journal of Clinical Endocrinology & Metabolism, 1982